Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine.
Ken Alltucker is a Health Reporter at USA Today. He specializes in watchdog journalism focusing on healthcare, covering a range of topics including the FDA, data analysis, and social issues related to health and wellness. Ken's work has been featured in numerous publications, including the Detroit Free Press, Yahoo News, and the Milwaukee Journal Sentinel.